These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 11964888)

  • 1. Severe community-acquired pneumonia: current outcomes, epidemiology, etiology, and therapy.
    Restrepo MI; Jorgensen JH; Mortensen EM; Anzueto A
    Curr Opin Infect Dis; 2001 Dec; 14(6):703-9. PubMed ID: 11964888
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antimicrobial treatment of community-acquired pneumonia.
    Restrepo MI; Anzueto A
    Clin Chest Med; 2005 Mar; 26(1):65-73. PubMed ID: 15802167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Guidelines-concordant empiric antimicrobial therapy and mortality in patients with severe community-acquired pneumonia requiring mechanical ventilation.
    Sakamoto Y; Yamauchi Y; Yasunaga H; Takeshima H; Hasegawa W; Jo T; Matsui H; Fushimi K; Nagase T
    Respir Investig; 2017 Jan; 55(1):39-44. PubMed ID: 28012492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of new therapies for severe community-acquired pneumonia.
    Restrepo MI; Anzueto A
    Curr Opin Infect Dis; 2006 Dec; 19(6):557-64. PubMed ID: 17075331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The emerging role of atypical pathogens in community-acquired pneumonia.
    Gleason PP
    Pharmacotherapy; 2002 Jan; 22(1 Pt 2):2S-11S; discussion 30S-32S. PubMed ID: 11791627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of empiric antimicrobial therapy with a β-lactam and fluoroquinolone on mortality for patients hospitalized with severe pneumonia.
    Mortensen EM; Restrepo MI; Anzueto A; Pugh J
    Crit Care; 2005 Dec; 10(1):R8. PubMed ID: 16420641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antimicrobial therapy in community-acquired pneumonia among emergency patients in a university hospital in Japan.
    Kawai S; Ochi M; Nakagawa T; Goto H
    J Infect Chemother; 2004 Dec; 10(6):352-8. PubMed ID: 15614461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evolution over a 15-year period of the clinical characteristics and outcomes of critically ill patients with severe community-acquired pneumonia.
    Vallés J; Diaz E; Martín-Loeches I; Bacelar N; Saludes P; Lema J; Gallego M; Fontanals D; Artigas A
    Med Intensiva; 2016 May; 40(4):238-45. PubMed ID: 26391738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Community-acquired lower respiratory tract infections: etiology and treatment.
    Guthrie R
    Chest; 2001 Dec; 120(6):2021-34. PubMed ID: 11742937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Community-acquired pneumonia in HIV-infected children: a global perspective.
    Gray DM; Zar HJ
    Curr Opin Pulm Med; 2010 May; 16(3):208-16. PubMed ID: 20375782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Severe pneumonia in the intensive care unit].
    Welte T
    Med Klin Intensivmed Notfmed; 2016 May; 111(4):279-89. PubMed ID: 27160261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Severe community-acquired pneumonia in adults: current antimicrobial chemotherapy.
    Niven DJ; Laupland KB
    Expert Rev Anti Infect Ther; 2009 Feb; 7(1):69-81. PubMed ID: 19622058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Epidemiology and Aetiology of Community-acquired Pneumonia (CAP)].
    Pletz MW; Rohde G; Schütte H; Bals R; von Baum H; Welte T;
    Dtsch Med Wochenschr; 2011 Apr; 136(15):775-80. PubMed ID: 21469047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Managing community-acquired pneumonia during flu season.
    Haessler S; Schimmel JJ
    Cleve Clin J Med; 2012 Jan; 79(1):67-78. PubMed ID: 22219236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Guidelines for the management of community-acquired pneumonia in children.
    Lee PI; Chiu CH; Chen PY; Lee CY; Lin TY;
    Acta Paediatr Taiwan; 2007; 48(4):167-80. PubMed ID: 18265536
    [No Abstract]   [Full Text] [Related]  

  • 16. Bacterial community-acquired pneumonia in children: changes in causative agents.
    Korppi M; Heiskanen-Kosma T
    Monaldi Arch Chest Dis; 2001 Apr; 56(2):132-6. PubMed ID: 11499302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Community-acquired pneumonia.
    Lynch JP; Martinez FJ
    Curr Opin Pulm Med; 1998 May; 4(3):162-72. PubMed ID: 9675519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors and outcome of community-acquired pneumonia due to Gram-negative bacilli.
    Falguera M; Carratalà J; Ruiz-Gonzalez A; Garcia-Vidal C; Gazquez I; Dorca J; Gudiol F; Porcel JM
    Respirology; 2009 Jan; 14(1):105-11. PubMed ID: 18699803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognosis factors and outcome of community-acquired pneumonia needing mechanical ventilation.
    Tejerina E; Frutos-Vivar F; Restrepo MI; Anzueto A; Palizas F; González M; Apezteguía C; Abroug F; Matamis D; Bugedo G; Esteban A;
    J Crit Care; 2005 Sep; 20(3):230-8. PubMed ID: 16253791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The correct approach to community-acquired pneumonia in immunocompetent adults: review of current guidelines.
    Carbonara S; Stano F; Scotto G; Monno L; Angarano G
    New Microbiol; 2008 Jan; 31(1):1-18. PubMed ID: 18437837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.